Dhwani Batra

Dhwani Batra

Auto-generated profile, based on publicly available information

Dhwani Batra

National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2022 in Science
Verified
Journal Article
Closed access
CGCrystal M. Gigante
Crystal M. Gigante
BKBette Tina Marie Korber
Bette Tina Marie Korber
MSMatthew Hunter Seabolt
Matthew Hunter Seabolt
KWKimberly Wilkins
Kimberly Wilkins
WDWhitni Davidson
Whitni Davidson
YLYu Li
Yu Li
Monkeypox is a viral zoonotic disease endemic in Central and West Africa. In May 2022, dozens of non-endemic countries reported hundreds of monkeypox cases, most with no epidemiological link to Africa. We identified two lineages of monkeypox virus (MPXV) among two 2021 and seven 2022 US monkeypox cases: the major 2022 outbreak variant called B.1 and a minor contemporaneously sampled variant called A.2. Analyses of mutations among these two variants revealed an extreme preference for GA-to-AA mutations indicative of human APOBEC3 cytosine deaminase activity among Clade IIb MPXV (previously West African, Nigeria) sampled since 2017. Such mutations were not enriched within other MPXV clades. These findings suggest that APOBEC3 editing may be a recurrent and a dominant driver of MPXV evolution within the current outbreak.

21 March 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
KLKristine Lacek
Kristine Lacek
BRBenjamin L. Rambo-Martin
Benjamin L. Rambo-Martin
DBDhwani Batra
Dhwani Batra
XZXiao-Yu Zheng
Xiao-Yu Zheng
HSHitoshi Sakaguchi
Hitoshi Sakaguchi
CPClinton R. Paden
Clinton R. Paden
Recombination between SARS-CoV-2 virus variants can result in different viral properties (e.g., infectiousness or pathogenicity). In this report, we describe viruses with recombinant genomes containing signature mutations from Delta and Omicron variants. These genomes are the first evidence for a Delta-Omicron hybrid Spike protein in the United States.